NZ591633A - Combination gas vaccines and therapeutics - Google Patents
Combination gas vaccines and therapeuticsInfo
- Publication number
- NZ591633A NZ591633A NZ591633A NZ59163309A NZ591633A NZ 591633 A NZ591633 A NZ 591633A NZ 591633 A NZ591633 A NZ 591633A NZ 59163309 A NZ59163309 A NZ 59163309A NZ 591633 A NZ591633 A NZ 591633A
- Authority
- NZ
- New Zealand
- Prior art keywords
- protein
- gas
- antigens
- mutant
- amino acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Gram-positive bacteria
- C07K16/1275—Streptococcus (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A61K2039/507—Comprising a combination of two or more separate antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9755108P | 2008-09-17 | 2008-09-17 | |
| PCT/IB2009/006949 WO2010076618A1 (en) | 2008-09-17 | 2009-09-17 | Combination gas vaccines and therapeutics |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ591633A true NZ591633A (en) | 2012-10-26 |
Family
ID=41508998
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ591633A NZ591633A (en) | 2008-09-17 | 2009-09-17 | Combination gas vaccines and therapeutics |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US20100136041A1 (https=) |
| EP (1) | EP2344523B1 (https=) |
| JP (2) | JP5680536B2 (https=) |
| CN (1) | CN102356090B (https=) |
| AU (1) | AU2009334428B2 (https=) |
| BR (1) | BRPI0919236A8 (https=) |
| CA (1) | CA2737453A1 (https=) |
| DK (1) | DK2344523T3 (https=) |
| ES (1) | ES2566740T3 (https=) |
| HR (1) | HRP20160306T1 (https=) |
| HU (1) | HUE027618T2 (https=) |
| MX (1) | MX2011002760A (https=) |
| NZ (1) | NZ591633A (https=) |
| PL (1) | PL2344523T3 (https=) |
| SI (1) | SI2344523T1 (https=) |
| SM (1) | SMT201600125B (https=) |
| WO (1) | WO2010076618A1 (https=) |
| ZA (1) | ZA201102005B (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0210128D0 (en) * | 2002-05-02 | 2002-06-12 | Chiron Spa | Nucleic acids and proteins from streptococcus groups A & B |
| HUE034251T2 (en) * | 2009-10-30 | 2018-02-28 | Glaxosmithkline Biologicals Sa | Purification of staphylococcus aureus type 5 and type 8 capsular saccharides |
| CN103239734B (zh) * | 2012-02-10 | 2016-02-24 | 北京艾棣维欣生物技术有限公司 | 用于预防和/或治疗呼吸道合胞病毒感染的疫苗 |
| GB201206366D0 (en) * | 2012-04-11 | 2012-05-23 | Absynth Biologics Ltd | Bacterial vaccine |
| JP6283674B2 (ja) * | 2012-09-18 | 2018-02-21 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 外膜小胞 |
| KR102730367B1 (ko) * | 2014-04-15 | 2024-11-15 | 그리피스 유니버시티 | 그룹 a 스트렙토코쿠스 백신 |
| BE1022553A1 (fr) * | 2014-05-07 | 2016-05-31 | Glaxosmithkline Biologicals Sa | Mutants de spy0269 |
| US10329601B2 (en) * | 2015-12-28 | 2019-06-25 | Ionian Technologies, Inc. | Nicking and extension amplification reaction (NEAR) of Streptococcus species |
| CN112442472B (zh) * | 2020-11-30 | 2023-05-26 | 四川大学华西医院 | 抗艰难梭菌的重组乳酸乳球菌、活载体疫苗及其制备方法 |
| JP7601913B2 (ja) * | 2021-01-19 | 2024-12-17 | デンカ株式会社 | タンパク質、溶血性連鎖球菌ワクチン、ｄｎａ、ベクター、形質転換体、タンパク質を製造する方法、バキュロウイルス、アグロバクテリウム、ラテックス粒子、キット及び抗ストレプトリジンｏ抗体の測定方法 |
| GB202215414D0 (en) | 2022-10-18 | 2022-11-30 | Glaxosmithkline Biologicals Sa | Vaccine |
| CN116875520B (zh) * | 2023-07-12 | 2024-06-14 | 吉林农业大学 | 表达核糖体失活蛋白的乳酸菌及其在抗轮状病毒中的应用 |
| CN120005039B (zh) * | 2025-01-10 | 2025-12-19 | 遵义医科大学珠海校区 | HtsA-SLOdm融合蛋白及其在制备A族链球菌疫苗中的应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8827038D0 (en) * | 1988-11-18 | 1988-12-21 | Kehoe M | Streptolysin o antigens & uses |
| US5866135A (en) * | 1994-04-21 | 1999-02-02 | North American Vaccine, Inc. | Group A streptococcal polysaccharide immunogenic compositions and methods |
| ES2505695T3 (es) * | 2003-07-31 | 2014-10-10 | Novartis Vaccines And Diagnostics, Inc. | Composiciones inmunógenas para Streptococcus pyogenes |
| US7838010B2 (en) * | 2004-10-08 | 2010-11-23 | Novartis Vaccines And Diagnostics S.R.L. | Immunogenic and therapeutic compositions for Streptococcus pyogenes |
| CA2668018A1 (en) * | 2006-10-30 | 2008-09-12 | Novartis Ag | Immunogenic and therapeutic compositions for streptococcus pyogenes |
| KR101621837B1 (ko) * | 2007-09-12 | 2016-05-17 | 노파르티스 아게 | Ｇａｓ57 돌연변이 항원 및 ｇａｓ57 항체 |
| EP2537857B1 (en) * | 2007-12-21 | 2017-01-18 | GlaxoSmithKline Biologicals SA | Mutant forms of streptolysin O |
-
2009
- 2009-09-17 NZ NZ591633A patent/NZ591633A/xx not_active IP Right Cessation
- 2009-09-17 WO PCT/IB2009/006949 patent/WO2010076618A1/en not_active Ceased
- 2009-09-17 SI SI200931421A patent/SI2344523T1/sl unknown
- 2009-09-17 AU AU2009334428A patent/AU2009334428B2/en active Active
- 2009-09-17 MX MX2011002760A patent/MX2011002760A/es active IP Right Grant
- 2009-09-17 DK DK09786278.3T patent/DK2344523T3/da active
- 2009-09-17 PL PL09786278.3T patent/PL2344523T3/pl unknown
- 2009-09-17 CA CA2737453A patent/CA2737453A1/en not_active Abandoned
- 2009-09-17 EP EP09786278.3A patent/EP2344523B1/en active Active
- 2009-09-17 CN CN200980142304.9A patent/CN102356090B/zh active Active
- 2009-09-17 BR BRPI0919236A patent/BRPI0919236A8/pt not_active Application Discontinuation
- 2009-09-17 HR HRP20160306TT patent/HRP20160306T1/hr unknown
- 2009-09-17 JP JP2011527423A patent/JP5680536B2/ja active Active
- 2009-09-17 HU HUE09786278A patent/HUE027618T2/en unknown
- 2009-09-17 US US12/561,619 patent/US20100136041A1/en not_active Abandoned
- 2009-09-17 ES ES09786278.3T patent/ES2566740T3/es active Active
-
2011
- 2011-03-16 ZA ZA2011/02005A patent/ZA201102005B/en unknown
-
2014
- 2014-11-13 US US14/540,627 patent/US20150132337A1/en not_active Abandoned
- 2014-11-25 JP JP2014237470A patent/JP2015038156A/ja not_active Withdrawn
-
2016
- 2016-04-29 SM SM201600125T patent/SMT201600125B/it unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN102356090B (zh) | 2016-01-20 |
| JP5680536B2 (ja) | 2015-03-04 |
| AU2009334428A1 (en) | 2010-07-08 |
| HRP20160306T1 (hr) | 2016-04-22 |
| EP2344523B1 (en) | 2016-02-10 |
| SI2344523T1 (sl) | 2016-06-30 |
| BRPI0919236A2 (pt) | 2015-12-15 |
| SMT201600125B (it) | 2016-07-01 |
| US20100136041A1 (en) | 2010-06-03 |
| WO2010076618A1 (en) | 2010-07-08 |
| BRPI0919236A8 (pt) | 2023-01-31 |
| MX2011002760A (es) | 2011-06-16 |
| CA2737453A1 (en) | 2010-07-08 |
| JP2012502969A (ja) | 2012-02-02 |
| AU2009334428B2 (en) | 2014-02-20 |
| JP2015038156A (ja) | 2015-02-26 |
| HUE027618T2 (en) | 2016-11-28 |
| DK2344523T3 (da) | 2016-04-18 |
| PL2344523T3 (pl) | 2016-09-30 |
| CN102356090A (zh) | 2012-02-15 |
| US20150132337A1 (en) | 2015-05-14 |
| ZA201102005B (en) | 2016-09-28 |
| EP2344523A1 (en) | 2011-07-20 |
| ES2566740T3 (es) | 2016-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ591633A (en) | Combination gas vaccines and therapeutics | |
| HRP20160638T1 (hr) | Antigen vezujući proteini sposobni vezati timusni stromalni limfopoetin | |
| BRPI0721003B8 (pt) | composições e uso | |
| NZ601615A (en) | Antibodies that bind to lysyl oxidase-like 2 (loxl2) and methods of use therefor | |
| JOP20190017B1 (ar) | أجسام مضادة ترتبط مع مستقبل cgrp بشري | |
| NZ600348A (en) | Anti-c5a binding moieties with high blocking activity | |
| RU2011111700A (ru) | Клостридиальные нейротоксины с измененной персистентностью | |
| ATE323721T1 (de) | Cholin-bindendes protein, welches als gegen pneumokokken gerichtetes vakzin verwendet wird | |
| WO2015048484A4 (en) | Binding moieties for biofilm remediation | |
| EA201270517A1 (ru) | Микобактериальные вакцины | |
| BR112014030797A2 (pt) | epítopo de peptídeo isolado, proteína recombinante, molécula de ácido nucléico isolada, vetor, célula hospedeira, método para preparar o epítopo de peptídeo ou mutante do mesmo, vacina de proteína, uso do epítopo de peptídeo ou mutante do mesmo, vacina de gene, uso da molécula de ácido nucléico, composição farmacêutica, anticorpo monoclonal e um fragmento de ligação ao antígeno do mesmo, linha de célula de hibridoma, kit, método para detecção da presença ou nível da proteína hbsag em uma amostra e uso do anticorpo monoclonal ou fragmento de ligação ao antígeno do mesmo | |
| GB201003701D0 (en) | System for the expression of a protein | |
| Okahashi et al. | Pili of oral Streptococcus sanguinis bind to fibronectin and contribute to cell adhesion | |
| WO2008127179A8 (en) | Fusion protein vaccine | |
| RU2009126617A (ru) | Собачий тимусный стромальный лимфопоэтический белок и его применение | |
| WO2008085962A3 (en) | Cell culture methods for producing recombinant proteins in the presence of reduced levels of one or more contaminants | |
| WO2010092176A3 (en) | Nontypable haemophilus influenzae antigens | |
| JP2012502969A5 (https=) | ||
| WO2008108830A3 (en) | Immunogenic and therapeutic compositions for streptococcus pyogenes | |
| NZ630920A (en) | Antibodies that neutralize rsv, mpv and pvm and uses thereof | |
| NZ702285A (en) | Staphylococcal coagulase antigens and methods of their use | |
| WO2009034473A3 (en) | Gas57 mutant antigens and gas57 antibodies | |
| Sakaguchi et al. | Genomics of Clostridium botulinum group III strains | |
| CN102942624B (zh) | 一种半乳糖凝集素-3结合蛋白及其制备和应用 | |
| DE602005018615D1 (de) | Schen polypeptiden und deren verwendung als impfstoffe und in der immuntherapie |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 17 SEP 2016 BY CPA GLOBAL Effective date: 20130801 |
|
| ERR | Error or correction |
Free format text: THE OWNER HAS BEEN CORRECTED TO 890887, NOVARTIS AG, LICHTSTRASSE 35, CH-4056 BASEL, CH Effective date: 20140409 |
|
| LAPS | Patent lapsed |